Ignite Creation Date:
2025-12-25 @ 4:02 AM
Ignite Modification Date:
2026-01-25 @ 12:02 AM
Study NCT ID:
NCT04042402
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-05-30
First Post:
2019-07-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Long Term Extension Study in Patients With Primary Hyperoxaluria
Sponsor:
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
DCR-PHXC-301
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None